181 related articles for article (PubMed ID: 18670875)
21. Venlafaxine for the control of hot flashes: results of a longitudinal continuation study.
Barton D; La Vasseur B; Loprinzi C; Novotny P; Wilwerding MB; Sloan J
Oncol Nurs Forum; 2002; 29(1):33-40. PubMed ID: 11817491
[TBL] [Abstract][Full Text] [Related]
22. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.
Loprinzi CL; Pisansky TM; Fonseca R; Sloan JA; Zahasky KM; Quella SK; Novotny PJ; Rummans TA; Dumesic DA; Perez EA
J Clin Oncol; 1998 Jul; 16(7):2377-81. PubMed ID: 9667254
[TBL] [Abstract][Full Text] [Related]
23. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.
Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; LaVasseur BI; Barton DL; Novotny PJ; Dakhil SR; Rodger K; Rummans TA; Christensen BJ
Lancet; 2000 Dec; 356(9247):2059-63. PubMed ID: 11145492
[TBL] [Abstract][Full Text] [Related]
24. Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial.
Caan B; LaCroix AZ; Joffe H; Guthrie KA; Larson JC; Carpenter JS; Cohen LS; Freeman EW; Manson JE; Newton K; Reed S; Rexrode K; Shifren J; Sternfeld B; Ensrud K
Menopause; 2015 Jun; 22(6):607-15. PubMed ID: 25405571
[TBL] [Abstract][Full Text] [Related]
25. Venlafaxine for hot flushes.
Barlow DH
Lancet; 2000 Dec; 356(9247):2025-6. PubMed ID: 11145483
[No Abstract] [Full Text] [Related]
26. Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors.
Biglia N; Torta R; Roagna R; Maggiorotto F; Cacciari F; Ponzone R; Kubatzki F; Sismondi P
Maturitas; 2005 Sep; 52(1):78-85. PubMed ID: 16143229
[TBL] [Abstract][Full Text] [Related]
27. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.
Nelson HD; Vesco KK; Haney E; Fu R; Nedrow A; Miller J; Nicolaidis C; Walker M; Humphrey L
JAMA; 2006 May; 295(17):2057-71. PubMed ID: 16670414
[TBL] [Abstract][Full Text] [Related]
28. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
29. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.
Loprinzi CL; Flynn PJ; Carpenter LA; Atherton P; Barton DL; Shanafelt TD; Rummans TA; Sloan JA; Adjei AA; Mincey BA; Fitch TR; Collins M
J Palliat Med; 2005 Oct; 8(5):924-30. PubMed ID: 16238505
[TBL] [Abstract][Full Text] [Related]
30. Flushing in a menopausal woman taking venlafaxine.
Grady-Weliky TA; Hartmann DM
Am J Psychiatry; 2001 Aug; 158(8):1330. PubMed ID: 11481177
[No Abstract] [Full Text] [Related]
31. Venlafaxine alters microvascular perfusion, [¹²³I]-beta-CIT binding and BDI scores in flushing postmenopausal women.
Sassarini J; Krishnadas R; Cavanagh J; Nicol A; Pimlott SL; Ferrell W; Lumsden MA
Maturitas; 2014 Mar; 77(3):267-73. PubMed ID: 24411555
[TBL] [Abstract][Full Text] [Related]
32. Clinical Inquiry: Do venlafaxine and gabapentin control hot flashes in women with a history of breast cancer?
Sarkissian A; Neher JO; Singh R; St Anna L
J Fam Pract; 2012 Dec; 61(12):759-72. PubMed ID: 23313996
[TBL] [Abstract][Full Text] [Related]
33. Beyond estrogen: new alternatives for the management of hot flashes.
Dvorak SR
S D J Med; 2002 Jan; 55(1):11-2. PubMed ID: 11808405
[No Abstract] [Full Text] [Related]
34. Clinical experience with venlafaxine in the treatment of hot flushes in women with a history of breast cancer.
van Gool AR; Bannink M; Bontenbal M; Seynaeve C
Neth J Med; 2005 May; 63(5):175-8. PubMed ID: 15952486
[TBL] [Abstract][Full Text] [Related]
35. Management of hot flashes in breast cancer survivors and men with prostate cancer.
Stearns V
Curr Oncol Rep; 2004 Jul; 6(4):285-90. PubMed ID: 15161582
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
Lee H; Kim JH; Min BH; Lee JH; Son HJ; Kim JJ; Rhee JC; Suh YJ; Kim S; Rhee PL
Am J Gastroenterol; 2010 Jul; 105(7):1504-12. PubMed ID: 20332772
[TBL] [Abstract][Full Text] [Related]
37. Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis.
Ramaswami R; Villarreal MD; Pitta DM; Carpenter JS; Stebbing J; Kalesan B
Breast Cancer Res Treat; 2015 Jul; 152(2):231-7. PubMed ID: 26067931
[TBL] [Abstract][Full Text] [Related]
38. Treatment for hot flushes in women receiving tamoxifen.
Bydder SA; Spry NA
Med J Aust; 2002 Sep; 177(5):266. PubMed ID: 12197825
[No Abstract] [Full Text] [Related]
39. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
Stearns V; Isaacs C; Rowland J; Crawford J; Ellis MJ; Kramer R; Lawrence W; Hanfelt JJ; Hayes DF
Ann Oncol; 2000 Jan; 11(1):17-22. PubMed ID: 10690382
[TBL] [Abstract][Full Text] [Related]
40. Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.
Sir A; D'Souza RF; Uguz S; George T; Vahip S; Hopwood M; Martin AJ; Lam W; Burt T
J Clin Psychiatry; 2005 Oct; 66(10):1312-20. PubMed ID: 16259546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
